1.

Conference Proceedings
Conference Proceedings
1. The development of clinical guidelines
Dukes G.N.M.
Pub. info.: Drug development, regulatory assessment, and postmarketing surveillance.  pp.61-63,  1981.  New York.  PLENUM PRESS
Title of ser.: NATO ASI series. Series A, Life sciences
Ser. no.: 39
2.

Conference Proceedings
Conference Proceedings
2. Sequential analysis: reply to the presentations
Dukes G.N.M.
Pub. info.: Drug development, regulatory assessment, and postmarketing surveillance.  pp.119-119,  1981.  New York.  PLENUM PRESS
Title of ser.: NATO ASI series. Series A, Life sciences
Ser. no.: 39
3.

Conference Proceedings
Conference Proceedings
3. A view on harmonization
Dukes G.N.M.
Pub. info.: Drug development, regulatory assessment, and postmarketing surveillance.  pp.169-171,  1981.  New York.  PLENUM PRESS
Title of ser.: NATO ASI series. Series A, Life sciences
Ser. no.: 39
4.

Conference Proceedings
Conference Proceedings
4. The effects of drug regulation: a systematic analysis
Dukes G.N.M. ; Lunde I.
Pub. info.: Drug development, regulatory assessment, and postmarketing surveillance.  pp.157-161,  1981.  New York.  PLENUM PRESS
Title of ser.: NATO ASI series. Series A, Life sciences
Ser. no.: 39
5.

Conference Proceedings
Conference Proceedings
5. New drug application submitted to the Erician Registration Committee(Clinical Section): Rejuvenal
Dukes G.N.M.
Pub. info.: Drug development, regulatory assessment, and postmarketing surveillance.  pp.270-274,  1981.  New York.  PLENUM PRESS
Title of ser.: NATO ASI series. Series A, Life sciences
Ser. no.: 39